Jarmo S. Salonen
- Pharmacology top 2%
- Pharmacology top 10%
- Oncology
- Molecular Biology
- Cellular and Molecular Neuroscience
- Co-authors
- Leena NymanOlavi PelkonenMats HidestrandMagnus Ingelman‐SundbergPäivi TaavitsainenMiia TurpeinenMikael OscarsonJyrki Taskinen
- Topics
- Pharmacogenetics and Drug Metabolism (11 papers)Eicosanoids and Hypertension Pharmacology (4 papers)Anesthesia and Sedative Agents (4 papers)
- Partner nations
- FinlandUnited KingdomSweden
In The Last Decade
Jarmo S. Salonen
17 papers receiving 384 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 212
- Pharmacology 95
- Oncology 92
- Molecular Biology 71
- Cellular and Molecular Neuroscience 54
Countries citing papers authored by Jarmo S. Salonen
This map shows the geographic impact of Jarmo S. Salonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarmo S. Salonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarmo S. Salonen more than expected).
Fields of papers citing papers by Jarmo S. Salonen
This network shows the impact of papers produced by Jarmo S. Salonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarmo S. Salonen. The network helps show where Jarmo S. Salonen may publish in the future.
Co-authorship network of co-authors of Jarmo S. Salonen
This figure shows the co-authorship network connecting the top 25 collaborators of Jarmo S. Salonen. A scholar is included among the top collaborators of Jarmo S. Salonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarmo S. Salonen. Jarmo S. Salonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 53 | |
| 3 | 55 | |
| 4 | 21 | |
| 5 | 15 | |
| 6 | CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes. | 77 |
| 7 | 46 | |
| 8 | 10 | |
| 9 | 18 | |
| 10 | 0 | |
| 11 | 10 | |
| 12 | 23 | |
| 13 | 20 | |
| 14 | 29 | |
| 15 | 8 | |
| 16 | 8 | |
| 17 | 6 | |
| 18 | 6 |
About Jarmo S. Salonen
Jarmo S. Salonen is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Biochemistry, having authored 18 papers that have together received 407 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Anesthesia and Sedative Agents (4 papers). The work is most often cited by research in Pharmacology (212 citations), Anesthesiology and Pain Medicine (45 citations) and Small Animals (47 citations). Jarmo S. Salonen has collaborated with scholars based in Finland, United Kingdom and Sweden. Frequent co-authors include Leena Nyman, Olavi Pelkonen, Mats Hidestrand, Magnus Ingelman‐Sundberg, Päivi Taavitsainen, Miia Turpeinen, Mikael Oscarson, Jyrki Taskinen, Markku Anttila and Mikko Koskinen. Their work appears in journals such as Analytical Biochemistry, Life Sciences and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.